Jynarque
Ended Awarded
- Contract number
- 36C24621N0571
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $14,345
Award facts
- Contract value 100% obligated
- $14,345.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a $14,345.31 firm fixed price delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 6 (VISN 6) on February 10, 2021, with a completion date of February 26, 2021. The contract, which was not issued under a set-aside designation, procures Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), reflecting the VA's streamlined procurement approach for critical medications supporting veterans' healthcare needs.
This delivery order is issued under a larger Indefinite Delivery Vehicle—specifically a Blanket Purchase Agreement valued at approximately $83.3 million for Jynarque that was awarded to Otsuka America Pharmaceutical Inc. by the VA's National Acquisition Center with an ultimate completion date of March 26, 2026. The BPA enables VA facilities across multiple Integrated Service Networks to efficiently order this specialized pharmaceutical treatment. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, is an established federal contractor that maintains substantial supply relationships with the VA, including a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, positioning the company as a key supplier of complex medications to the Veterans Health Administration.
Quick answers
Who was awarded contract 36C24621N0571?
36C24621N0571 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on February 10, 2021.
How much is contract 36C24621N0571 worth?
The government has obligated $14,345 on 36C24621N0571.
Is contract 36C24621N0571 an order under another contract?
Yes. 36C24621N0571 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24621N0571 competed?
The extent of competition for 36C24621N0571 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award